Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantation. Grimm J, Jentzsch M, Bill M, Backhaus D, et al. Am J Hematol 2021;96:1287-1294.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Grimm J, Jentzsch M, Bill M, Backhaus D, et al. Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantation. Am J Hematol 2021;96:1287-1294.
PMID: 34289154